GSK3 at the Edge: Regulation of Developmental Specification and Cell Polarization

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|11|1411-1419

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.11, 2006-11, pp. : 1411-1419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GSK3 Inhibitors and Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 9, 2009-08 ,pp. : 1024-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

By Aubry Jean-Michel   Schwald Michèle   Ballmann Eladia   Karege Félicien  

Psychopharmacology, Vol. 205, Iss. 3, 2009-08 ,pp. : 419-429

Springer Publishing Company

Access to resources Recommend Favorite

GSK-3 and the neurodevelopmental hypothesis of schizophrenia

By Kozlovsky N.   Belmaker R.H.   Agam G.  

European Neuropsychopharmacology, Vol. 12, Iss. 1, 2002-02 ,pp. : 13-25

Elsevier

Access to resources Recommend Favorite

GSK-3 Inhibitors: Discoveries and Developments

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 755-763

Bentham Science Publishers

Access to resources Recommend Favorite

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite